Document is current

Any future updates will be listed below

A retrospective study of docetaxel or paclitaxel in patients with advanced or recurrent esophageal squamous cell carcinoma who previously received fluoropyrimidine- and platinum-based chemotherapy

Crossref DOI link: https://doi.org/10.1007/s00280-014-2597-3

Published Online: 2014-09-30

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark